-
1
-
-
70449516435
-
The allogeneic graft-versus-cancer effect
-
Ringden O, Karlsson H, Olsson R, Omazic B, Uhlin M. The allogeneic graft-versus-cancer effect. Br J Haematol 2009; 147:614-33.
-
(2009)
Br J Haematol
, vol.147
, pp. 614-633
-
-
Ringden, O.1
Karlsson, H.2
Olsson, R.3
Omazic, B.4
Uhlin, M.5
-
2
-
-
1542299089
-
Nonmyeloablative allogeneic immunotherapy for solid tumors
-
Childs RW, Barrett J. Nonmyeloablative allogeneic immunotherapy for solid tumors. Annu Rev Med 2004; 55:459-75.
-
(2004)
Annu Rev Med
, vol.55
, pp. 459-475
-
-
Childs, R.W.1
Barrett, J.2
-
3
-
-
77954860536
-
CMV central nervous system disease in stem-cell transplant recipients: An increasing complication of drug-resistant CMV infection and protracted immunodeficiency
-
Reddy SM, Winston DJ, Territo MC, Schiller GJ. CMV central nervous system disease in stem-cell transplant recipients: an increasing complication of drug-resistant CMV infection and protracted immunodeficiency. Bone Marrow Transplant 2010; 45:979-84.
-
(2010)
Bone Marrow Transplant
, vol.45
, pp. 979-984
-
-
Reddy, S.M.1
Winston, D.J.2
Territo, M.C.3
Schiller, G.J.4
-
4
-
-
13444256480
-
Immune reconstitution and clearance of human adenovirus viremia in pediatric stemcell recipients
-
Heemskerk B, Lankester AC, van Vreeswijk T, et al. Immune reconstitution and clearance of human adenovirus viremia in pediatric stemcell recipients. J Infect Dis 2005; 191:520-30.
-
(2005)
J Infect Dis
, vol.191
, pp. 520-530
-
-
Heemskerk, B.1
Lankester, A.C.2
Van Vreeswijk, T.3
-
5
-
-
70349663887
-
Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction
-
Omar H, Hagglund H, Gustafsson-Jernberg A, et al. Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction. Transpl Infect Dis 2009; 11:393-9.
-
(2009)
Transpl Infect Dis
, vol.11
, pp. 393-399
-
-
Omar, H.1
Hagglund, H.2
Gustafsson-Jernberg, A.3
-
6
-
-
33746936633
-
The role of HLA mismatch, splenectomy and recipient Epstein-Barr virus seronegativity as risk factors in post-transplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation
-
Sundin M, Le Blanc K, Ringden O, et al. The role of HLA mismatch, splenectomy and recipient Epstein-Barr virus seronegativity as risk factors in post-transplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation. Haematologica 2006; 91:1059-67.
-
(2006)
Haematologica
, vol.91
, pp. 1059-1067
-
-
Sundin, M.1
Le Blanc, K.2
Ringden, O.3
-
7
-
-
79955591917
-
Decreased IL-7 signaling in T cells from patients with PTLD after allogeneic HSCT
-
Omar H, Ahmed R, Rane L, et al. Decreased IL-7 signaling in T cells from patients with PTLD after allogeneic HSCT. J Immunother 2011; 34:390-6.
-
(2011)
J Immunother
, vol.34
, pp. 390-396
-
-
Omar, H.1
Ahmed, R.2
Rane, L.3
-
8
-
-
0036467791
-
High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: Evidence for indirect effects of primary CMV infection
-
Nichols WG, Corey L, Gooley T, Davis C, Boeckh M. High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infection. J Infect Dis 2002; 185:273-82.
-
(2002)
J Infect Dis
, vol.185
, pp. 273-282
-
-
Nichols, W.G.1
Corey, L.2
Gooley, T.3
Davis, C.4
Boeckh, M.5
-
9
-
-
79953758894
-
Influence of donor cytomegalovirus (CMV) status on severity of viral reactivation after allogeneic stem cell transplantation in CMV-seropositive recipients
-
Pietersma FL, van Dorp S, Minnema MC, et al. Influence of donor cytomegalovirus (CMV) status on severity of viral reactivation after allogeneic stem cell transplantation in CMV-seropositive recipients. Clin Infect Dis 2011; 52:e144-8.
-
(2011)
Clin Infect Dis
, vol.52
-
-
Pietersma, F.L.1
Van Dorp, S.2
Minnema, M.C.3
-
10
-
-
51049108165
-
Management of CMV, HHV-6, HHV-7 and Kaposi-sarcoma herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCT
-
Ljungman P, de la Camara R, Cordonnier C, et al. Management of CMV, HHV-6, HHV-7 and Kaposi-sarcoma herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCT. Bone Marrow Transplant 2008; 42:227-40.
-
(2008)
Bone Marrow Transplant
, vol.42
, pp. 227-240
-
-
Ljungman, P.1
De La Camara, R.2
Cordonnier, C.3
-
11
-
-
0037082453
-
Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation
-
Reusser P, Einsele H, Lee J, et al. Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation. Blood 2002; 99:1159-64.
-
(2002)
Blood
, vol.99
, pp. 1159-1164
-
-
Reusser, P.1
Einsele, H.2
Lee, J.3
-
12
-
-
33846015837
-
Treatment of adenovirus disease in stem cell transplant recipients with cidofovir
-
Neofytos D, Ojha A, Mookerjee B, et al. Treatment of adenovirus disease in stem cell transplant recipients with cidofovir. Biol Blood Marrow Transplant 2007; 13:74-81.
-
(2007)
Biol Blood Marrow Transplant
, vol.13
, pp. 74-81
-
-
Neofytos, D.1
Ojha, A.2
Mookerjee, B.3
-
13
-
-
20244382569
-
Increased incidence of EBV-related disease following paediatric stem cell transplantation with reducedintensity conditioning
-
Cohen J, Gandhi M, Naik P, et al. Increased incidence of EBV-related disease following paediatric stem cell transplantation with reducedintensity conditioning. Br J Haematol 2005; 129:229-39.
-
(2005)
Br J Haematol
, vol.129
, pp. 229-239
-
-
Cohen, J.1
Gandhi, M.2
Naik, P.3
-
14
-
-
0036624737
-
Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy
-
Einsele H, Roosnek E, Rufer N, et al. Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy. Blood 2002; 99:3916-22.
-
(2002)
Blood
, vol.99
, pp. 3916-3922
-
-
Einsele, H.1
Roosnek, E.2
Rufer, N.3
-
15
-
-
0028816546
-
Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation
-
Rooney CM, Smith CA, Ng CY, et al. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet 1995; 345:9-13.
-
(1995)
Lancet
, vol.345
, pp. 9-13
-
-
Rooney, C.M.1
Smith, C.A.2
Ng, C.Y.3
-
16
-
-
12944328008
-
Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: Prophylactic infusion of EBV-specific cytotoxic T cells
-
Gustafsson A, Levitsky V, Zou JZ, et al. Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV-specific cytotoxic T cells. Blood 2000; 95:807-14.
-
(2000)
Blood
, vol.95
, pp. 807-814
-
-
Gustafsson, A.1
Levitsky, V.2
Zou, J.Z.3
-
17
-
-
0028820386
-
Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor
-
Walter EA, Greenberg PD, Gilbert MJ, et al. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med 1995; 333:1038-44.
-
(1995)
N Engl J Med
, vol.333
, pp. 1038-1044
-
-
Walter, E.A.1
Greenberg, P.D.2
Gilbert, M.J.3
-
18
-
-
73349108055
-
A novel haplo-identical adoptive CTL therapy as a treatment for EBV-associated lymphoma after stem cell transplantation
-
Uhlin M, Okas M, Gertow J, Uzunel M, Brismar TB, Mattsson J. A novel haplo-identical adoptive CTL therapy as a treatment for EBV-associated lymphoma after stem cell transplantation. Cancer Immunol Immunother 2010; 59:473-7.
-
(2010)
Cancer Immunol Immunother
, vol.59
, pp. 473-477
-
-
Uhlin, M.1
Okas, M.2
Gertow, J.3
Uzunel, M.4
Brismar, T.B.5
Mattsson, J.6
-
19
-
-
79951655904
-
Directly selected cytomegalovirus-reactive donor T cells confer rapid and safe systemic reconstitution of virus-specific immunity following stem cell transplantation
-
Peggs KS, Thomson K, Samuel E, et al. Directly selected cytomegalovirus-reactive donor T cells confer rapid and safe systemic reconstitution of virus-specific immunity following stem cell transplantation. Clin Infect Dis 2011; 52:49-57.
-
(2011)
Clin Infect Dis
, vol.52
, pp. 49-57
-
-
Peggs, K.S.1
Thomson, K.2
Samuel, E.3
-
20
-
-
79952470341
-
Adoptive transfer and selective reconstitution of streptamer-selected cytomegalovirus-specific CD8+ T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantation
-
Schmitt A, Tonn T, Busch DH, et al. Adoptive transfer and selective reconstitution of streptamer-selected cytomegalovirus-specific CD8+ T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantation. Transfusion 2011; 51:591-9.
-
(2011)
Transfusion
, vol.51
, pp. 591-599
-
-
Schmitt, A.1
Tonn, T.2
Busch, D.H.3
-
21
-
-
79953716579
-
Storage of buffy-coat-derived platelets in additive solution: In vitro effects on platelets of the air bubbles and foam included in the final unit
-
Sandgren P, Saeed K. Storage of buffy-coat-derived platelets in additive solution: in vitro effects on platelets of the air bubbles and foam included in the final unit. Blood Transfus 2011; 9:182-8.
-
(2011)
Blood Transfus
, vol.9
, pp. 182-188
-
-
Sandgren, P.1
Saeed, K.2
-
22
-
-
0037262169
-
Quantitative analysis of chimerism after allogeneic bone marrow transplantation using immunomagnetic selection and fluorescent microsatellite PCR
-
Hancock JP, Goulden NJ, Oakhill A, Steward CG. Quantitative analysis of chimerism after allogeneic bone marrow transplantation using immunomagnetic selection and fluorescent microsatellite PCR. Leukemia 2003; 17:247-51.
-
(2003)
Leukemia
, vol.17
, pp. 247-251
-
-
Hancock, J.P.1
Goulden, N.J.2
Oakhill, A.3
Steward, C.G.4
-
23
-
-
0038580791
-
A real-time TaqMan PCR for routine quantitation of cytomegalovirus DNA in crude leukocyte lysates from stem cell transplant patients
-
Yun Z, Lewensohn-Fuchs I, Ljungman P, Ringholm L, Jonsson J, Albert J. A real-time TaqMan PCR for routine quantitation of cytomegalovirus DNA in crude leukocyte lysates from stem cell transplant patients. J Virol Methods 2003; 110:73-9.
-
(2003)
J Virol Methods
, vol.110
, pp. 73-79
-
-
Yun, Z.1
Lewensohn-Fuchs, I.2
Ljungman, P.3
Ringholm, L.4
Jonsson, J.5
Albert, J.6
-
24
-
-
0033966914
-
Development of a real-time quantitative assay for detection of Epstein-Barr virus
-
Niesters HG, van Esser J, Fries E, Wolthers KC, Cornelissen J, Osterhaus AD. Development of a real-time quantitative assay for detection of Epstein-Barr virus. J Clin Microbiol 2000; 38:712-5.
-
(2000)
J Clin Microbiol
, vol.38
, pp. 712-715
-
-
Niesters, H.G.1
Van Esser, J.2
Fries, E.3
Wolthers, K.C.4
Cornelissen, J.5
Osterhaus, A.D.6
-
25
-
-
49949107392
-
Quantification of adenovirus DNA in unrelated donor hematopoietic stem cell transplant recipients
-
Gustafson I, Lindblom A, Yun Z, et al. Quantification of adenovirus DNA in unrelated donor hematopoietic stem cell transplant recipients. J Clin Virol 2008; 43:79-85.
-
(2008)
J Clin Virol
, vol.43
, pp. 79-85
-
-
Gustafson, I.1
Lindblom, A.2
Yun, Z.3
-
26
-
-
78149413548
-
Leukemia lineage-specific chimerism analysis and molecular monitoring improve outcome of donor lymphocyte infusions
-
Sairafi D, Remberger M, Uhlin M, Ljungman P, Ringden O, Mattsson J. Leukemia lineage-specific chimerism analysis and molecular monitoring improve outcome of donor lymphocyte infusions. Biol Blood Marrow Transplant 2010; 16:1728-37.
-
(2010)
Biol Blood Marrow Transplant
, vol.16
, pp. 1728-1737
-
-
Sairafi, D.1
Remberger, M.2
Uhlin, M.3
Ljungman, P.4
Ringden, O.5
Mattsson, J.6
-
27
-
-
0029100438
-
Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients
-
Kolb HJ, Schattenberg A, Goldman JM, et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 1995; 86:2041-50.
-
(1995)
Blood
, vol.86
, pp. 2041-2050
-
-
Kolb, H.J.1
Schattenberg, A.2
Goldman, J.M.3
-
28
-
-
0033962014
-
Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia
-
Dazzi F, Szydlo RM, Craddock C, et al. Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia. Blood 2000; 95:67-71.
-
(2000)
Blood
, vol.95
, pp. 67-71
-
-
Dazzi, F.1
Szydlo, R.M.2
Craddock, C.3
-
29
-
-
73349108055
-
A novel haplo-identical adoptive CTL therapy as a treatment for EBVassociated lymphoma after stem cell transplantation
-
Uhlin M, Okas M, Gertow J, Uzunel M, Brismar TB, Mattsson J. A novel haplo-identical adoptive CTL therapy as a treatment for EBVassociated lymphoma after stem cell transplantation. Cancer Immunol Immunother 2010; 59:473-7.
-
(2010)
Cancer Immunol Immunother
, vol.59
, pp. 473-477
-
-
Uhlin, M.1
Okas, M.2
Gertow, J.3
Uzunel, M.4
Brismar, T.B.5
Mattsson, J.6
-
30
-
-
78049278080
-
Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes
-
Barker JN, Doubrovina E, Sauter C, et al. Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes. Blood 2010; 116:5045-9.
-
(2010)
Blood
, vol.116
, pp. 5045-5049
-
-
Barker, J.N.1
Doubrovina, E.2
Sauter, C.3
-
31
-
-
13244260712
-
Cytomegalovirus disease before hematopoietic cell transplantation as a risk for complications after transplantation
-
Fries BC, Riddell SR, Kim HW, et al. Cytomegalovirus disease before hematopoietic cell transplantation as a risk for complications after transplantation. Biol Blood Marrow Transplant 2005; 11:136-48.
-
(2005)
Biol Blood Marrow Transplant
, vol.11
, pp. 136-148
-
-
Fries, B.C.1
Riddell, S.R.2
Kim, H.W.3
-
32
-
-
83555166294
-
Adenovirus infection in paediatric allogeneic stem cell transplantation recipients is a major independent factor for significantly increasing the risk of treatment related mortality
-
George D, El-Mallawany NK, Jin Z, et al. Adenovirus infection in paediatric allogeneic stem cell transplantation recipients is a major independent factor for significantly increasing the risk of treatment related mortality. Br J Haematol 2012; 156:99-108.
-
(2012)
Br J Haematol
, vol.156
, pp. 99-108
-
-
George, D.1
El-Mallawany, N.K.2
Jin, Z.3
-
33
-
-
33750621679
-
Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation
-
Brunstein CG, Weisdorf DJ, DeFor T, et al. Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation. Blood 2006; 108:2874-80.
-
(2006)
Blood
, vol.108
, pp. 2874-2880
-
-
Brunstein, C.G.1
Weisdorf, D.J.2
Defor, T.3
-
34
-
-
0029887429
-
European survey of herpesvirus resistance to antiviral drugs in bone marrow transplant recipients
-
Reusser P, Cordonnier C, Einsele H, et al. European survey of herpesvirus resistance to antiviral drugs in bone marrow transplant recipients. Bone Marrow Transplant 1996; 17:813-7.
-
(1996)
Bone Marrow Transplant
, vol.17
, pp. 813-817
-
-
Reusser, P.1
Cordonnier, C.2
Einsele, H.3
-
35
-
-
34548025068
-
Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: Results of a phase 2 multicenter clinical trial
-
Haque T, Wilkie GM, Jones MM, et al. Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial. Blood 2007; 110:1123-31.
-
(2007)
Blood
, vol.110
, pp. 1123-1131
-
-
Haque, T.1
Wilkie, G.M.2
Jones, M.M.3
-
36
-
-
13044295992
-
Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease
-
Khanna R, Bell S, Sherritt M, et al. Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease. Proc Natl Acad Sci USA 1999; 96:10391-6.
-
(1999)
Proc Natl Acad Sci USA
, vol.96
, pp. 10391-10396
-
-
Khanna, R.1
Bell, S.2
Sherritt, M.3
-
37
-
-
80051907647
-
Expansion of T cells targeting multiple antigens of cytomegalovirus Epstein-Barr virus and adenovirus to provide broad antiviral specificity after stem cell transplantation
-
Hanley PJ, Shaffer DR, Cruz CR, et al. Expansion of T cells targeting multiple antigens of cytomegalovirus, Epstein-Barr virus and adenovirus to provide broad antiviral specificity after stem cell transplantation. Cytotherapy 2011; 13:976-86.
-
(2011)
Cytotherapy
, vol.13
, pp. 976-986
-
-
Hanley, P.J.1
Shaffer, D.R.2
Cruz, C.R.3
-
38
-
-
77951058615
-
Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells
-
Moosmann A, Bigalke I, Tischer J, et al. Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells. Blood 2010; 115:2960-70.
-
(2010)
Blood
, vol.115
, pp. 2960-2970
-
-
Moosmann, A.1
Bigalke, I.2
Tischer, J.3
-
39
-
-
23744516707
-
Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers
-
Cobbold M, Khan N, Pourgheysari B, et al. Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers. J Exp Med 2005; 202:379-86.
-
(2005)
J Exp Med
, vol.202
, pp. 379-386
-
-
Cobbold, M.1
Khan, N.2
Pourgheysari, B.3
-
40
-
-
70349658396
-
Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: A comprehensive review of reported cases
-
Styczynski J, Einsele H, Gil L, Ljungman P. Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases. Transpl Infect Dis 2009; 11:383-92.
-
(2009)
Transpl Infect Dis
, vol.11
, pp. 383-392
-
-
Styczynski, J.1
Einsele, H.2
Gil, L.3
Ljungman, P.4
-
41
-
-
33845586418
-
Single agent efficacy of rituximab in childhood immunosuppression related lymphoproliferative disease: A United Kingdom Children's Cancer Study Group (UKCCSG) retrospective review
-
Messahel B, Taj MM, Hobson R, et al. Single agent efficacy of rituximab in childhood immunosuppression related lymphoproliferative disease: a United Kingdom Children's Cancer Study Group (UKCCSG) retrospective review. Leuk Lymphoma 2006; 47:2584-9.
-
(2006)
Leuk Lymphoma
, vol.47
, pp. 2584-2589
-
-
Messahel, B.1
Taj, M.M.2
Hobson, R.3
-
42
-
-
0032573604
-
Results of different strategies for reducing cytomegalovirus-associated mortality in allogeneic stem cell transplant recipients
-
Ljungman P, Aschan J, Lewensohn-Fuchs I, et al. Results of different strategies for reducing cytomegalovirus-associated mortality in allogeneic stem cell transplant recipients. Transplantation 1998; 66: 1330-4.
-
(1998)
Transplantation
, vol.66
, pp. 1330-1334
-
-
Ljungman, P.1
Aschan, J.2
Lewensohn-Fuchs, I.3
-
43
-
-
0242416961
-
Cellular responses to cytomegalovirus in immunosuppressed patients: Circulating CD8+ T cells recognizing CMVpp65 are present but display functional impairment
-
Engstrand M, Lidehall AK, Totterman TH, Herrman B, Eriksson BM, Korsgren O. Cellular responses to cytomegalovirus in immunosuppressed patients: circulating CD8+ T cells recognizing CMVpp65 are present but display functional impairment. Clin Exp Immunol 2003; 132:96-104.
-
(2003)
Clin Exp Immunol
, vol.132
, pp. 96-104
-
-
Engstrand, M.1
Lidehall, A.K.2
Totterman, T.H.3
Herrman, B.4
Eriksson, B.M.5
Korsgren, O.6
-
44
-
-
74049116602
-
Generation of EBV-specific cytotoxic T cells that are resistant to calcineurin inhibitors for the treatment of posttransplantation lymphoproliferative disease
-
Brewin J, Mancao C, Straathof K, et al. Generation of EBV-specific cytotoxic T cells that are resistant to calcineurin inhibitors for the treatment of posttransplantation lymphoproliferative disease. Blood 2009; 114:4792-803.
-
(2009)
Blood
, vol.114
, pp. 4792-4803
-
-
Brewin, J.1
Mancao, C.2
Straathof, K.3
-
45
-
-
73449085640
-
Generation of Epstein-Barr virus-specific cytotoxic T lymphocytes resistant to the immunosuppressive drug tacrolimus (FK506)
-
De Angelis B, Dotti G, Quintarelli C, et al. Generation of Epstein-Barr virus-specific cytotoxic T lymphocytes resistant to the immunosuppressive drug tacrolimus (FK506). Blood 2009; 114:4784-91.
-
(2009)
Blood
, vol.114
, pp. 4784-4791
-
-
De Angelis, B.1
Dotti, G.2
Quintarelli, C.3
-
46
-
-
38149117105
-
Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates
-
Berger C, Jensen MC, Lansdorp PM, Gough M, Elliott C, Riddell SR. Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates. J Clin Invest 2008; 118:294-305.
-
(2008)
J Clin Invest
, vol.118
, pp. 294-305
-
-
Berger, C.1
Jensen, M.C.2
Lansdorp, P.M.3
Gough, M.4
Elliott, C.5
Riddell, S.R.6
-
47
-
-
80053997259
-
A human memory T cell subset with stem cell-like properties
-
Gattinoni L, Lugli E, Ji Y, et al. A human memory T cell subset with stem cell-like properties. Nat Med 2011; 17:1290-7.
-
(2011)
Nat Med
, vol.17
, pp. 1290-1297
-
-
Gattinoni, L.1
Lugli, E.2
Ji, Y.3
|